Fredrik Erlandsson

Chief Medical Officer Purespring Therapeutics

Seminars

Thursday 18th March 2027
Clinical Development of AAV Based Gene Therapies for Glomerular Diseases
11:30 am
  • Expected side effects of AAV-based gene therapies, and mitigation strategies
  • Operationalizing gene therapies in nephrology
  • Current and coming clinical gene therapies targeting glomerular diseases
fredrik erlandsson Speaker at 8th CKD Summit